Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)

NCT00607854

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Service d'hématologie - CHU de Besançon Besançon, France
  • Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Bordeaux - Pessac, France
  • Service d'hématologie - CHU Hôtel Dieu Clermont-Ferrand Clermont-Ferrand, France
  • Service de médecine nucléaire - Centre de Lutte contre le Cancer de la Région Auvergne Jean Perrin Clermont-Ferrand, France
View Trial Details
Completed

Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

NCT00147121

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Aichi Medical University Aichi-gun,Nagakute,Yazako,Karimata,21, Aichi-ken, Japan
  • Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya,Mizuho-ku,Mizuho-cho,Kawasumi,1, Aichi-ken, Japan
  • Nagoya University School of Medicine Nagoya,Showa-ku, Tsurumai-cho,65, Aichi-ken, Japan
View all 45 locations
View Trial Details
Completed

Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma

NCT00798096

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Stanford, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Boston, Massachusetts, United States
View Trial Details
Completed

Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma

NCT00446095

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Stanford, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View Trial Details
Completed

Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

NCT01015248

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • ICO-Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
  • ICO-Hospital Durans i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Mutua de Terrassa Terrassa, Barcelona, Spain
View all 19 locations
View Trial Details
Completed

Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

NCT00786851

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Ospedale SS. Antonio Biagio e Cesare Arrigo Alessandria, Italy
  • Centro diriferimento oncologico Aviano (PN), Italy
  • Ematologia Spedali Civili Brescia, Italy
  • Ematologia Ospedale Businco Cagliari, Italy
View all 17 locations
View Trial Details

Related conditions